In mice models of AD and PD, a FUS-mediated BBB disruption has been shown to enhance the brain’s concentration of amyloid and tau antibodies, neurotrophic factors, and GSK-3 inhibitors [212,213,214]. The gene discussed is MAPT; the disease is Alzheimer disease.